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Developing Service Delivery Measures 
for Studies of Practice Variation:  
The MPROVE Study 
 
Glen Mays, PhD, MPH  
University of Kentucky 
AcademyHealth Public Health Systems Research Interest Group Meeting  •  Orlando, FL   •  27 June 2012 
Down 
the briar 
patch 
we go… 
Multi-Network Practice and Outcome 
Variation Examination Study (MPROVE) 
• Identify service delivery measures for selected, high-value 
public health services 
• Create a registry of measures collected consistently across 
local communities   
• Profile geographic variation in the delivery of selected public 
health services across local communities 
• Decompose variation into attributable components:  
– need-sensitive or preference-sensitive factors 
– supply-sensitive factors 
• Examine associations between service delivery & outcomes 
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Participating MPROVE networks 
4 
Network 
State 
Agencies 
Local 
Agencies* 
Academic 
Units Other Total 
Lead 
Institution 
CO 1 55 2 15 73 Association 
FL 1 67 3 3 74 Local agency 
MN 1 75 1 1 78 State agency 
WA 1 36 2 1 40 Local agency 
NJ 1 100 2 1 104 Academic 
TN 1 16 2 1 20 Academic 
Total 6 349 12 22 389 
Overview of Activities and Timeline 
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May 
2012 
October 
2012 
September 
2013 
April 
2013 
• Selection and specification 
of “core” measures to collect 
across networks 
• Selection and specification 
of additional “local” 
measures to collect within 
networks 
• Development of analysis 
plans 
• Data collection 
• Pooling data across 
networks 
• Data analysis 
• Within network 
• Across networks 
• Interpretation and 
translation 
• Development of initial 
dissemination products  
• Planning for future &  
follow-up studies 
Phase I Phase II Phase III 
MPROVE Measure Domains 
• Communicable disease control 
• Chronic disease prevention 
• Environmental health protection 
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MPROVE Measure Selection & Specification 
• Call for measures to identify inventory of candidate measures 
• Literature review to identify candidate measures 
• Delphi expert rating of measures based on selection criteria 
• Value of Information (VOI) analysis of first-tier measures 
• Discussion and modification of ratings  
• Final selection of “core” measures 
• Development of measure specifications 
• Final approval of measure specifications 
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MPROVE Measurement Dimensions 
• Availability/scope: are selected services/activities produced or 
performed by the public health agency or delivery system  
• Volume/intensity: absolute or relative frequency of service 
delivery over a given unit of time 
• Capacity: ratio of inputs to size of the relevant target 
population or risk (e.g. sanitarians per 1000 septic tanks, food 
safety inspectors per 1000 licensed food vendors)   
• Reach: percent of the target population reached by the activity 
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MPROVE Measurement Dimensions 
• Quality-Appropriateness: Does the public health agency 
and/or system act based on objectively measured health 
needs and risk profiles of the population served?  What is the 
degree of concordance between a community’s documented 
health needs/risks and the scope of public health activities 
performed by the public health agency or the system as a 
whole?  
9 
MPROVE Measurement Dimensions 
• Quality-Effectiveness/Fidelity: Does the public health agency 
and/or system implement its activities based on available scientific 
knowledge and fidelity to evidence-based guidelines?  To what 
extent are programs and services concordant with evidence-based 
guidelines and professional consensus standards? 
• Quality-Timeliness:  Are public health activities implemented at the 
appropriate points in time to maximize health protection and 
minimize the risk of disease transmission or injury?    
• Quality-Community Centeredness/Engagement: To what extent are 
relevant stakeholders engaged in planning, priority-setting, 
selection, and implementation of public health activities undertaken 
by the public health agency and/or system?  To what extent are 
public health activities tailored appropriately to at-risk population 
groups based on the groups’ values, preferences, needs, knowledge, 
skills, and resources?   
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MPROVE Measurement Dimensions 
• Quality-Efficiency:  To what extent are public health activities 
implemented in ways that optimize the use of financial and 
human resources?  To what extent do implementation 
processes avoid waste and delays in service?  To what extent 
do the benefits of public health activities justify their costs?   
• Quality-Equity:  Are there disparities in the reach of public 
health activities to different population sub-groups defined by 
personal characteristics such as race, ethnicity, geography, or 
socio-economic status?  Are there disparities in effectiveness, 
timeliness, community-centeredness, and/or efficiency?  
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MPROVE Measurement Dimensions 
12 
HHS Quality Aims* Measurement Dimensions 
Population-centered Community-centered 
Equitable Equity 
Proactive Timeliness 
Health-promoting Effectiveness/fidelity 
Risk-reducing Effectiveness/fidelity 
Vigilant Appropriateness 
Effective Effectiveness/fidelity 
Efficient Efficiency 
*Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services.  
Priority Areas for the Improvement of Quality in Public Health.  The Public Health Quality Forum.  
Washington, D.C.: U.S. Department of Health and Human Services; 2010.  
Selection Criteria 
• Domain: Degree to which the measure falls within one of the 
three core domains of activity for this study: communicable 
disease control; chronic disease prevention; environmental 
health protection 
• Dimension: Degree to which the measure addresses one or 
more of the key dimensions of service delivery for this study: 
availability, volume/intensity, capacity, reach, and/or quality.   
• Relevance/Control: Degree to which the measure reflects an 
activity that local public health agencies and/or their partners 
have the authority (law) and organizational responsibility 
(mission) to implement 
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Selection Criteria 
• Expected Health Impact: Degree to which improvements in 
the measured activity are expected to result in improvements 
in population health.   
• Expected Economic Impact: Degree to which changes in the 
measured activity are expected to result in changes in the cost 
of delivering public health services, changes in the cost of 
delivering other health care or social services (spill over), 
and/or other changes in the direct and indirect costs of 
preventable illness/injury/disability.   
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Selection Criteria 
• Expected Variation: Degree to which the measured activity is expected to 
vary across local public health settings, vary across states/PBRN networks, 
and vary over time.   
• Feasibility:  Degree to which it is economically and logistically feasible to 
obtain the data needed to construct the measure at the level of the local 
public health practice setting for all/most/many practice settings in each 
participating PBRN.   
• Expected Validity: Degree to which the measure characterizes the public 
health activity of interest. 
• Expected Reliability: Degree to which the measure characterizes the 
activity consistently across different local public health settings and over 
time 
15 
Selecting Measures Based on Expected 
Health Impact: a VOI Approach 
• Proportion of the population currently exposed to the risk 
factor(s) addressed by the measured activity [risk exposure] 
• Proportion of the exposed population that is expected to be 
reached by the measured activity [expected reach]  
• Relative risk of the health outcome(s) comparing the exposed 
to the unexposed population [preventable fraction] 
• Relative risk of the health outcome(s) comparing the 
population reached by the measured activity to the population 
not reached [efficacy]   
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AL Siu, EA McGlynn, et al. 1992 
Example VOI Calculation 
• Activity to Measure: Community-wide campaigns to increase physical 
activity, rated as “Strong Evidence of Effectiveness” in Community Guide 
• Risk Exposure (Adults):  64% failure to receive recommended PA dose 
• Preventable fraction: 24% reduction in premature mortality 
• Efficacy: median net improvement of 4% in receipt of recommended PA 
• Expected Reach:  30% 
• Impact fraction: expected proportional reduction in the outcome 
attributable to improvement of the measured activity 
    = 0.64 * 0.30 * 0.04 * 0.24 
  =  0.00184 
 
 
 
 
 
17 Task Force on Community Preventive Services. Recommendations to increase physical activity in 
communities.  Am J Prev Med 2002;22 (4S):67-72. 
Conclusions 
• Test the utility of the PBRN model for standardized 
measurement, data collection, and analysis 
• Select “high value” measures to improve rigor and relevance 
of research 
• Use geographic variation studies for hypothesis generation,  
QI targeting, cost studies, natural experiments, theory-driven 
sampling frames 
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